USDA Gives Industrial Hemp Farming The Green Light

Author: Ryan Tengco

As more and more people realize the benefits of Cannabidiol (CBD), the industry continues to grow by leaps and bounds. As a result, farmers across the entire country will soon be able to grow hemp in an industrial fashion under the guidance of the United States Domestic Hemp Production Program. This program was announced just a few days ago by the United States Department of Agriculture (USDA). This announcement is a huge milestone hemp industry and for countless farmers who are looking to expand into the fast growing hemp market.

One of the reasons why the government regulators decided to give this program the go-ahead is that the United States Department of Agriculture (USDA) is always looking for ways to provide new economic opportunities for farmers. The USDA knows that farming is an important cornerstone of the country’s economy. The opportunity to grow hemp should provide openings for new products and markets. They have worked hard to come up with a regulatory framework that will work well for this rapidly growing industry. Under the new program, farmers will be able to grow hemp in every state as well as on reservations. This should provide a fair opportunity to all that is based on consistent regulations established by the government.

New Requirements Under the Program

Of course, the USDA has a handful of regulations regarding the program to ensure that it is conducted both fairly and safely. Those who decide to grow hemp will need to obtain a license from the proper regulatory authorities. They will also need to maintain records of their business and have their products tested for THC levels on a regular basis. Furthermore, the USDA is also going to set up rules and requirements for the disposal of plants that do not meet the requirements of the new program. These regulations are going to help farmers grow their hemp in a safe, consistent, and fair manner.

A Rapid Increase in the Demand for CBD Products

One of the main reasons why the USDA decided to go ahead with this new program is that there has been a rapid rise in the demand for products containing CBD (cannabidiol). There have already been published research studies investigating the use of CBD as a treatment option for a variety of medical conditions. Some people have claimed that CBD can help those who suffer from chronic pain, anxiety, epilepsy, and other medical conditions. In some cases, CBD might be used to help families who might not have any other option. Many authorities believe that the potential of CBD to help with these conditions has led to a rapid rise in demand. Therefore, the USDA decided that is was time to give this program a green light.

The Projected Growth of the Industry

As the demand for CBD has grown, so has the industry. Some financial studies have expected the sales of various CBD products to total more than $20 billion in the United States by the year 2024. In addition, the sales of CBD products are various CBD dispensaries rose from six percent in 2017 to 11 percent in 2018, nearly doubling. In this sense, many economic leaders believe that a transformation is taking place when it comes to CBD products. It is growing from a sub-category to a full-blown industry and should be treated as such. This creates a tremendous opportunity for those who are looking to become more involved with the growth of CBD.

Source Link:

Study Shows Using Chemo and CBD for Cancer Triples Survival Rates

Author: Aaron Cadena

One of the most popular topics in the industry today is using hemp-derived CBD for Cancer.

With only slight changes in life expectancy over the last 40 years and cancer rates on the rise, cancer is an epidemic of the modern world with experts everywhere searching for a solution, synthetic or natural.

With chemotherapy being one of the most widely practiced cancer treatments, some experts believe a natural treatment could be more effective.

Due to its unique properties and effectiveness in providing relief for many other conditions, experts have looked to Cannabidiol (CBD), the non-psychoactive Cannabis compound, as a realistic solution, and have seen positive results.

With human lives at stake here, the ultimate question is, which is more effective?

With strong arguments on both sides, a study just published in July 2018 may indicate that neither side is right or wrong.
CBD for pancreatic cancer
In the study, researchers found that when using Chemotherapy with CBD for cancer, it inhibited the proliferation rate of cancer cells and tripled the survival rate of mice with pancreatic cancer.

That’s right. Tripled.

While some might say that this is a singular situation or a luck of the draw, research indicates otherwise.

A 2013 study found that the combination of therapies decreased the reproduction of cancer cells, while many others found that the combination actually helped repair damaged cells and helped maintain the balance of healthy cells in the body.

CBD is still classified as a schedule 1 drug in the United States, and because of this it cannot be used in human trials; however, in other countries where CBD is seen as a medical breakthrough, medical professionals are finding consistent and positive results when treating human cancer patients with CBD.

David DiSalvo of Forbes puts in his statement on the study: “The more we learn about the potential of these compounds, the more it seems clear that decades of research being blocked by federal law deprived us of medical advances that are only now starting to surface.”

While federal law may continue to impede research, and some “experts” will continue to claim that the findings are “inconclusive,” the evidence is starting to stack up and become overwhelming clear – CBD could just be the miracle we need in our fight against cancer.

Source Link: